active
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
A break of .001 could be a very good sign.
Not much volume at all traderdogzz. Maybe they are still sleeping this morning.
Especially if their staff actually had real expertise ( Ex. scientists) in the field of alternative energies and can actually offer the company real consultation specifically targeted upon wind/solar/alternative fuel technologies..
Post #21815 Answer ... Yes it is, the website belongs to Brian Holden in Las Vegas Nevada.
www.jatrophaproducers.com
A fair enough statement Kilgore. Have a good evening sir.
Is this the new IR group ? http://www.jatrophaproducers.com/company-view.php?cid=49
Now that was funny video!
Unfortunately I do not know, perhaps that is a question for PharmaCom BioVet Inc.'s investor relations to answer.
What's wrong with obtaining additional media exposure ? Emerging companies, most unable to afford their own investor relations division or consulting professionals, are usually challenged in the best of times to be visible to the investment community. Subscriber based newsletters, company profiles on the internet websites and subscriber based emails are not unacceptable means of advertising.
Hi Tina :)
They can't go straight up forever, pull backs are healthy for all stocks.
I see that some people took advantage of the KDSC dip today.
Good evening Monk.
Education, one cannot argue with that if it takes precedence over work. Thanks
Q. What happened to the previous IR representatives?
PHMB .0007 +40% for the day, chart ;
PHMB .0007 +40% for the day, chart ;
lol
Agreed.
And if they have planned a joint effort with PetScreenLTD or another entity that specializes in the field as a professional, would the statement be false?
In all honesty though, that sounds like another fantastic question for the company, their investor relations department or company SEC filings ( if any since it's a pinksheet ) . Perhaps a much better place to get answers to those questions than investorshub and I'm sure ALL can agree on that.
* BUT in a colloborative effort with PetScreenLTD, that statement is null and void ...
In a recent letter from PetScreen LTD's CEO, Dr. Kevin Slater, the collaboration between the two companies is seen as an important step forward in improving cancer diagnosis and treatment for companion animals.
PharmaCom BioVet, Inc. Announces Cancer Care Centers to Incorporate Significant Benefits of Lymphoma Blood Tests for Canine Cancer Treatments
Tuesday , November 18, 2008 17:25ET
RALEIGH, NC -- (Marketwire) -- 11/18/08 -- PharmaCom BioVet, Inc. (PINKSHEETS: PHMB). PharmaCom BioVet, Inc. is pleased to announce the incorporation of PetScreen LTD into their companion animal treatment centers and the benefits of PetScreen, LTD's Lymphoma Blood Testing in the treatment of canine cancer treatments.
PharmaCom BioVet, Inc. President and CEO, Gary Berthold has confirmed plans to promote and incorporate current Lymphoma Blood Testing programs developed by PetScreen LTD of Nottingham, UK into its new canine cancer treatments centers. In a recent letter from PetScreen LTD's CEO, Dr. Kevin Slater, the collaboration between the two companies is seen as an important step forward in improving cancer diagnosis and treatment for companion animals. "Lymphoma is one of the most common forms of cancer in dogs and accounts for a significant percentage of cancer deaths," Berthold noted. "The Canine Lymphoma Blood Test procedure pioneered by PetScreen will provide our treatment centers, and veterinarians everywhere, with a very simple means of testing for the disease."
"The benefits are wide ranging and will aid in the screening, diagnosis and monitoring of lymphoma treatments programs," Berthold continued. "This process is highly valuable in tracking the efficacy of various levels of treatment as well as the overall results from radio pharmaceutical usage. Of equal importance is its ability to provide vital information once a patient's cancer has gone into remission. It will allow us to better determine how the treatment worked and, consequently, how to replicate those results," he added.
"Our recent collaboration with PetScreen LTD further enables us to provide effective, state-of-the-art canine cancer treatment programs within our treatment centers," offered Berthold. "Our goal is to help lead the way towards the highest achievements possible in cancer care for companion animals. One of the key factors in attaining this goal is the formation of synergistic relationships with professionals around the country and the world. With each collaboration, we are working to assemble the best minds in the field of cancer research and veterinary oncology. Combined with leading edge technologies and procedures, such as Lymphoma Blood Testing, our hope is to accelerate the progress towards optimum treatment results and an eventual cure," he concluded.
PetScreen LTD, founded by Dr. Slater and Board Chairman, Professor Graeme Radcliffe, was established to provide veterinarians with improved testing methodologies in order to help them make better diagnostic and treatment decisions for companion animals with cancer. The company features a comprehensive range of services and a growing cooperative network of industry professionals.
PharmaCom BioVet, Inc. is the inspiration of Gary and Sharon Berthold of Raleigh, NC. Avid Siberian Husky breeders and life-long dog lovers, the Berthold's were driven to establish the company following the loss of two of their most precious Siberian Huskies to cancer. While researching medical remedies, they discovered a growing nationwide demand for canine cancer care along with an astonishing lack of effective treatment options. To address these realities, they formed PharmaCom BioVet, Inc. to establish canine cancer treatment centers around the country. These facilities will link the brightest veterinary leaders with the latest oncology technologies to offer the most advanced cancer treatment programs available.
About PharmaCom BioVet, Inc.:
PharmaCom BioVet, Inc. is dedicated to advancing the veterinary care industry for companion animals by establishing state-of-the-art treatment centers for lymphoma and other forms of cancer throughout the country. The purpose of these centers is to help prolong the quality of life for companion animals with cancer and pursue the potential for complete cure. These centers will also operate under the philosophy of providing a compassionate care environment for both companion animal patients and their owners. For more information, please visit our website PharmaCom BioVet, Inc..
About PetScreen, LTD:
PetScreen LTD. is headquartered and operates laboratories in Nottingham, England. Its purpose is to develop and apply new technologies directed towards improving cancer diagnosis and treatment in dogs and other companion animals. Their facilities offer services such as Canine Lymphoma Blood Tests, which provide veterinarians with a simple means of screening, diagnosis and monitoring treatment of dogs with lymphoma. Their DCA program (Directed Chemotherapy Assay) helps in determining the most effective chemotherapy treatment for each individual canine cancer patient. From their UK location, they have developed a network of national and international collaborators to provide services and support to the veterinary cancer patient. For more information, please visit the website at Pet-Screen.com - Fighting cancer in dogs and cats.
About IsoTherapeutics Group, LLC:
The mission of IsoTherapeutics Group, LLC is to develop novel diagnostic and therapeutic agents for the treatment of severe diseases. ITG both develops their own technologies as well as partners with other companies to help develop pharmaceuticals. Of special interest are radiopharmaceuticals for oncology. In house expertise includes synthetic organic chemistry, chelation chemistry, radiochemistry, diagnostic and therapeutic isotopes, conjugation chemistry, pharmacokinetics, and small animal research models. For more information, please visit our website Home.
When we work with companies, all announcements, website information and filings all be believed to be true and accurate. Especially since we have no ther reason to believe otherwise.
Now if for some reason, down the road, they were found to be issuing false information.. I agree 100% that themeselves and others alike who issue false information should face regulatory issues for possibly misleading the public domain... if that was the case but at this point, the company is a start up.. nothing more, nothing less.
A speculative business and a speculative investment ( long or short term )
That's a fair statement. Is there factual information to believe that they have not hired or plan to hire a medical professional for services. ?
AHD 6.15 now + 1.97 ...
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=34575063
Another question would be, is it typical for companies to reveal their company business plan for all to see ? Feedback is much appreciated, thanks.
It certainly does. Those also sound like fantastic questions to send into the company or to their investor relations department.
VCA Antech, Inc. does pretty well with freestanding veterinary hospitals and veterinary-exclusive clinical laboratories. At this point, it's quite clear that PharmaCom is a highly speculative investment whether it be long or short term. Such is the case for most penny stocks, especially in today's marketplace, even goliaths such as Washington Mutual, Lehman Brothers and others ( as everyone knows ) have been victims of horrific market conditions.
http://finapps.forbes.com/finapps/jsp/finance/compinfo/CashFlows.jsp?tkr=WOOF&period=qtr
* Please do not misconstrue this message. i am not stating that PHMB will be the next WOOF, I'm simply stating that success does exist within the industry.
The size of the industry gives little indication to the expected profitability of the individual firm. The housing market is very large but is not expected to do well in 2009. The pet care market might be characterized as discretionary and may not do well in an off economy.
Management history is the single most valid predictor in this situation. Take a closer look at Manny and Gary.
FRE printing .85 now +.12
FRE .8381 new high of day ;
ABK 1.51 ;
AHD 5.20 + 1.02 ;
CBAY 151 million in volume, all buys at .0001
One left @ .0001 right now ;
One left on CBAY right now ;
Maybe that's their next one.
Appetite for seduction or plain old destruction?
Burger King FLAME Body Spray SOLD OUT!
Despite eliciting "universal disgust," the new Burger King FLAME™ body spray has sold out at all Ricky's locations AND on the website! Marisol, an employee at the Ricky's on First Avenue between 64th and 65th Streets, says their original shipment of 24 sold out within a matter of days, and frustrated "FLAMERS" have been calling constantly to try and track down a bottle. Although same haters compared the product's scent to the aroma of "a Burger King burning down in a horrible grease fire," Marisol told us it sold out because it smelled "nice. And spicy. It kind of smelled like Axe body spray." Why must you taunt us, Marisol!?! Okay, nobody panic; Grub Street comforts frustrated FLAME™ consumers with news that it's being sold on eBay for $76 (and rising). Or just wait until January (if you can!), when Ricky's will be getting more FLAME™ in stock.
http://gothamist.com/2008/12/22/burger_king_flame_body_spray_sold_o.php
KDSC chart ;
Live streaming "X" quotes on your website now ?
Stochastic oscillator is registering a strong bullish signal and it is no longer oversold. PHMB has also been moving up from it's 52 week low of .0002 in a fairly orderly fashion as of late. MACD seems to be trending above the signal line as well.